搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
TCTMD
10 小时
Incorrect Arm Positions Overestimate Blood Pressure Measurements
A study reinforces the importance of supporting the arm and placing the BP cuff at heart level, as guidelines recommend.
TCTMD
10 小时
Different Guidelines for Acute PE Offer a Mixed Bag of Advice
Guideline recommendations for acute pulmonary embolism (PE) developed by prominent professional societies give a mixed bag of advice across the US and Europe, according to a paper published online ...
TCTMD
1 天
AI-Measured Breast Artery Calcification Tied to CV Outcomes in Women
The incidental mammogram finding isn’t a reason to panic, but it might a reason to make sure other risk factors are under ...
TCTMD
6 天
FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades
With a much longer half-life than other radiotracers, flurpiridaz F-18 will boost patient access to PET imaging, one expert ...
TCTMD
4 天
Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome
The randomized study lasted just 3 months, but researchers saw “multiple cardiometabolic benefits” beyond weight loss.
TCTMD
6 天
FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?
In one study, outcomes were similar regardless of baseline LVEF and recent worsening HF emerged as an important indicator.
TCTMD
4 天
Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM
Two new analyses from HELIOS-B answer important questions, but some uncertainties remain, says Julie Rosenthal.
TCTMD
5 天
‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF
Whether a drug that selectively targets fat mass, with modest weight loss, translates into CV benefits awaits further study.
TCTMD
7 天
Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity
Indications that the GLP-1 drug has greater benefits in the most frail patients should be viewed cautiously, one expert says.
TCTMD
6 天
‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM
While promising, questions remain about sustained long-term benefits of cardiac myosin inhibitors and their impact on ...
TCTMD
5 天
EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER
Postmarket data on MitraClip lend further support to the idea that this subgroup fares as well as the overall SMR population.
TCTMD
7 天
TCTMD’s Top 10 Most Popular Stories for September 2024
Most of our top stories this month stemmed from the ESC Congress—a mix of drug and device trials as well as guidelines.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈